Release Date: 09/10/18 11:43 Summary: Syntonic Investor Presentation Price Sensitive: No Download Document 2.71MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%